IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells

Molecular Immunology

Volumn 46, Issue 10, 2009, Pages 2045-2053

  Shen, Yuqing ^a   Xia, Mei ^a   Zhang, Jianqiong ^a   Xu, Lianhong ^a   Yang, Jin ^a   Chen, Aiqin ^a   Miao, Fengqin ^a   Ferrone, Soldano ^b   Xie, Wei ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Hepatocellular carcinoma; HLA A antigens; Interferon regulatory factor 1; Transcription activation; Transcription factor p65

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; INTERFERON REGULATORY FACTOR 1; LUCIFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR P65; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENHANCER REGION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGEN PRESENTATION; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A ANTIGENS; HUMANS; INTERFERON REGULATORY FACTOR-1; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 65549151902     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.03.001     Document Type: Article

References (32)

1. Bi Y.C., Zhang J.Q., Hong Z.H., Huang J., Chen J.G., Wang X.H., Ferrone S., and Xie W. Association of HLA class I antigen expression in human carcinoma with improved prognosis. Tissue Antigens 59s2 (2002) 105-106
2. Blanchet O., Gazin C., L'Haridon M., Tatari Z., Degos L., Sigaux F., and Paul P. Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11. Int. Immunol. 6 (1994) 1485-1496
3. Bodmer W.F., Browning M.J., Krausa P., Rowan A., Bicknell D.C., and Bodmer J.G. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N. Y. Acad. Sci. 690 (1993) 42-49
4. Bouker K.B., Skaar T.C., Riggins R.B., Harburger D.S., Fernandez D.R., Zwart A., Wang A., and Clarke R. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26 (2005) 1527-1535
5. Campoli M., and Ferrone S. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27 (2008) 5869-5885
6. Chang C.C., Campoli M., and Ferrone S. HLA class I defects in malignant lesions: what have we learned?. Keio J. Med. 52 (2003) 220-229
7. Chen M., Peng M.L., Shi Q.F., and Ren H. Establishing a L02 cell model with whole HBV gene transfection and analyzing its expressions of HLA-A, B, C and MICA/B. Zhonghua Gan Zang Bing Za Zhi 15 (2007) 417-421 (in Chinese)
8. Chen W., Cai M.Y., Wei D.P., and Wang X. Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J. Gastroenterol. 11 (2005) 3297-3299
9. Chen Y., Cheng M., and Tian Z. Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell Mol. Immunol. 3 (2006) 373-378
10. Chen Z.J., Yang H., Liu C.C., Hirai S., and Ferrone S. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen. Cancer Res. 53 (1993) 112-119
11. Dolganiuc A., Norkina O., Kodys K., Catalano D., Bakis G., Marshall C., Mandrekar P., and Szabo G. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133 (2007) 1627-1636
12. Facoetti A., Nano R., Zelini P., Morbini P., Benericetti E., Ceroni M., Campoli M., and Ferrone S. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin. Cancer Res. 11 (2005) 8304-8311
13. Herzer K., Falk C.S., Encke J., Eichhorst S.T., Ulsenheimer A., Seliger B., and Krammer P.H. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J. Virol. 77 (2003) 8299-8309
14. Huang J., Cai M.Y., and Wei D.P. HLA class I expression in primary hepatocellular carcinoma. World J. Gastroenterol. 8 (2002) 654-657
15. Girdlestone J. Synergistic induction of HLA class I expression by RelA and CIITA. Blood 95 (2000) 3804-3808
16. Gobin S.J., Keijsers V., van Zutphen M., and van den Elsen P.J. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J. Immunol. 161 (1998) 2276-2283
17. Griffioen M., Ouwerkerk I.J., Harten V., Gobin S.J., van den Elsen P.J., and Schrier P.I. Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines. Immunogenetics 49 (1999) 287-294
18. Lefebvre S., Moreau P., Dausset J., Carosella E.D., and Paul P. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA. Placenta 20 (1999) 293-301
19. Masuda K., Hiraki A., Fujii N., Watanabe T., Tanaka M., Matsue K., Ogama Y., Ouchida M., Shimizu K., Ikeda K., and Tanimoto M. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci. 98 (2007) 102-108
20. Mehta A.M., Jordanova E.S., Kenter G.G., Ferrone S., and Fleuren G.J. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol. Immunother. 57 (2008) 197-206
21. Meraro D., Gleit-Kielmanowicz M., Hauser H., and Levi B.Z. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J. Immunol. 168 (2002) 6224-6231
22. Molinero L.L., Fuertes M.B., Girart M.V., Fainboim L., Rabinovich G.A., Costas M.A., and Zwirner N.W. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J. Immunol. 173 (2004) 5583-5590
23. Naschberger E., Werner T., Vicente A.B., Guenzi E., Töpolt K., Leubert R., Lubeseder-Martellato C., Nelson P.J., and Stürzl M. Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 379 (2004) 409-420
24. Ogino T., Shigyo H., Ishii H., Katayama A., Miyokawa N., Harabuchi Y., and Ferrone S. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res. 66 (2006) 9281-9289
25. Pandha H., Rigg A., John J., and Lemoine N. Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines. Clin. Exp. Immunol. 148 (2007) 127-135
26. Raffaghello L., Prigione I., Airoldi I., Camoriano M., Morandi F., Bocca P., Gambini C., Ferrone S., and Pistoia V. Mechanisms of immune evasion of human neuroblastoma. Cancer Lett. 228 (2005) 155-161
27. Rolland P., Deen S., Scott I., Durrant L., and Spendlove I. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer. Clin. Cancer Res. 13 (2007) 3591-3596
28. Sernee M.F., Ploegh H.L., and Schust D.J. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 35 (1998) 177-188
29. Vollmer Jr. C.M., Eilber F.C., Butterfield L.H., Ribas A., Dissette V.B., Koh A., Montejo L.D., Lee M.C., Andrews K.J., McBride W.H., Glaspy J.A., and Economou J.S. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res. 59 (1999) 3064-3067
30. Wang X., Liang B., Rebmann V., Lu J., Celis E., Kageshita T., Grosse-Wilde H., and Ferrone S. Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens 62 (2003) 139-148
31. Wetzler M., Baer M.R., Stewart S.J., Donohue K., Ford L., Stewart C.C., Repasky E.A., and Ferrone S. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 15 (2001) 128-133
32. Xia M., Zhang J.Q., Shen Y.Q., Xu L.H., Chen A.Q., Miao F.Q., and Xie W. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma. Tissue Antigens 70 (2007) 272-282